9.4 Study Completion, Electrode Removal & Infection Prevention
Key Takeaways
Electrode removal begins by identifying the adhesive and following its manufacturer instructions, the approved chemical list, ventilation/PPE requirements, and accessible Safety Data Sheet.
Support the skin and soften adhesive before slow removal; stop and escalate pain, bleeding, blistering, skin separation, or an unexpected chemical reaction.
Cleaning and disinfection depend on actual use, device IFU, and infection-prevention policy; single-use items are never reprocessed and electronics are not immersed unless permitted.
Suspected prion exposure requires containment and immediate consultation with infection prevention rather than a technologist-invented universal disposal rule.
The completion record includes data verification, scalp findings, equipment disposition, patient tolerance, and all escalation or follow-up actions.
9.4 Study Completion, Electrode Removal & Infection Prevention
The conclusion of a long-term video-EEG monitoring study requires the same technical rigor, clinical vigilance, and safety standards as study initiation. The neurodiagnostic technologist is responsible for systematically discontinuing recording equipment, safely removing scalp electrodes without causing epidermal trauma, conducting a thorough dermatological scalp assessment, educating the patient on post-study skin care, and executing rigorous infection control and equipment reprocessing protocols in strict compliance with OSHA, CDC, and ASET guidelines.
1. Study Discontinuation Workflow & Patient Safety Checkpoint
Before disconnecting a single lead, the technologist must complete a structured study discontinuation checklist:
+-----------------------------------------------------------------------------+
| STUDY DISCONTINUATION OPERATIONAL CHECKLIST |
| |
| [1] PHYSICIAN ORDER VERIFICATION |
| - Verify formal physician order for study discontinuation in EMR |
| - Confirm with epileptologist that adequate diagnostic data / ictal |
| events have been successfully captured |
| - Verify that anti-seizure medications (ASMs) have been resumed and |
| therapeutic blood levels reached before EMU discharge |
| |
| [2] FINAL ELECTROPHYSIOLOGICAL ARCHIVE & CALIBRATION |
| - Perform final post-study impedance check on all channels |
| - Record a 2-minute post-study bio-calibration and resting baseline |
| - Place official software discontinuation marker in the EEG file |
| - Terminate digital acquisition and initiate server data sync/backup |
| |
| [3] PATIENT DISCONNECTION & HEADBOX DETACHMENT |
| - Safely disconnect headbox cable from wall jack / acquisition base |
| - Remove auxiliary polygraphic leads (ECG, EMG, EOG, respiratory) |
| - Prepare solvent tray and protective barrier drapes |
+-----------------------------------------------------------------------------+
2. Safe Electrode De-application and Adhesive Removal
Identify the adhesive and consult its manufacturer instructions before choosing a remover. Collodion, medical adhesive, paste, tape, and cyanoacrylate products do not share one universal solvent. Verify allergy history, ventilation, flammability precautions, eye/airway protection, and the facility’s approved chemical list. The Safety Data Sheet must be accessible for each remover.
Soften or dissolve the adhesive for the IFU-specified time and remove the electrode slowly in the direction of hair growth while supporting the skin. Do not pull a cup by its wire, scrape the scalp, saturate the face, or use an unapproved solvent. Acetone and other volatile products require particular attention to flammability, vapor, mucosal exposure, damaged skin, and local policy; their use is not described correctly by either “always required” or “universally forbidden.” Stop for pain, bleeding, skin separation, or an unexpected reaction and obtain clinical help.
After removal, account for every electrode and inspect the entire scalp under good light. Document site, size, color, blanching, skin loss, drainage, pain, and any device-related pressure injury using the organization’s terminology. Notify nursing or the responsible clinician for nonblanching erythema, blister, erosion, bleeding, swelling, drainage, or other injury. Cleaning, dressing, and discharge instructions follow the clinician’s order and wound-care policy; the technologist does not independently prescribe treatment.
3. Cleaning, Disinfection, and Reprocessing
Device classification depends on how the item was actually used and whether it contacted intact skin, nonintact skin, mucous membrane, sterile tissue, or blood. First remove visible soil, because disinfection cannot substitute for cleaning. Then use the device manufacturer’s validated reprocessing instructions and the facility infection-prevention policy, including product dilution, contact time, material compatibility, rinsing, drying, inspection, and storage.
Reusable scalp cups and lead assemblies are not automatically assigned one universal Spaulding level in every circumstance. Skin abrasion, an open site, contamination, and the manufacturer’s labeling can change the requirement. Single-use electrodes are discarded after one patient. Needles and intracranial contacts are sterile single-use devices unless the manufacturer explicitly provides a validated alternative. Never immerse a headbox or connector unless its IFU permits immersion.
At handoff, separate clean and dirty workflow. Wear indicated PPE, prevent sharps injury, place sharps immediately into an approved container, transport contaminated reusable items in a closed labeled container, and store processed items dry and protected from recontamination. Document a failed cleaning cycle, damaged insulation, corrosion, or a missing item and remove unsafe equipment from service.
4. Suspected Prion Disease
Prion precautions are uncommon and require immediate coordination with infection prevention, neurology, the device manufacturer, and the organization’s prion policy. Do not rely on routine disinfection for an item that may be subject to special prion reprocessing, and do not declare every lead or electronic component “incineration only.” Identify which patient-contact items are single-use, which can be quarantined pending a decision, and which have a validated prion procedure. Keep potentially contaminated items segregated and labeled; do not return them to normal circulation.
For the examination, the safe decision rule is escalation and containment: use disposable patient-contact supplies when directed, minimize reusable equipment at the bedside, avoid unnecessary contamination, and follow the current institutional and public-health protocol for quarantine, reprocessing, or disposal. Protect the chain of identification and document exactly what contacted the patient.
5. Completion Checklist
- Confirm the physician-approved stop order and that required events/data were captured.
- Save and verify the final record, annotations, impedances, and technical summary before disconnecting.
- Coordinate medication, fall, and discharge precautions with nursing; removal of electrodes does not end seizure risk.
- Remove electrodes using the adhesive IFU, approved chemical, PPE, and ventilation controls.
- Inspect and document the scalp; escalate injury or infection concerns.
- Segregate single-use, reusable, sharps, chemical, and electronic waste correctly.
- Reprocess reusable equipment under the manufacturer and infection-prevention policy.
- Record completion, equipment disposition, skin findings, patient tolerance, and any follow-up action.
What is the safest way to choose a remover for a collodion- or adhesive-secured scalp electrode?
Use acetone for every patient because all adhesives are chemically identical.
Use the adhesive manufacturer’s approved remover and instructions, with facility chemical policy, PPE, ventilation, and mucosal/skin precautions.
Pull the electrode by its wire without softening the adhesive.
Mix two solvents to speed removal.
How should a reusable scalp electrode be reprocessed after a study?
Apply one universal intermediate-level disinfectant regardless of use or manufacturer.
Rinse briefly and return it to the clean bin while wet.
Clean visible soil, then follow the device manufacturer’s validated reprocessing instructions and facility infection-prevention policy for its actual use; inspect and dry before clean storage.
Autoclave every lead wire and headbox.
A patient is placed on precautions for suspected Creutzfeldt-Jakob disease after EEG supplies have been used. What should the technologist do?
Return all reusable items to normal circulation after an alcohol wipe.
Independently incinerate the electronic headbox.
Segregate and label potentially affected items, use disposable supplies as directed, and contact infection prevention for the current prion quarantine/reprocessing/disposal protocol.
Hide the exposure to avoid losing equipment.
Upon removing scalp electrodes following a 4-day EMU monitoring study, the technologist observes non-blanchable erythema over the intact skin of the C3 electrode site beneath where a tight elastic wrap was placed. How should the technologist classify this finding and what immediate action is required?
Stage 3 full-thickness pressure injury; requires immediate surgical debridement
Allergic contact dermatitis; requires prescription oral corticosteroids
Stage 1 pressure injury; cleanse gently with normal saline, apply a moisturizing skin barrier, and document in the EHR
Normal post-study finding; no documentation or skin care is needed
Sections you finish are checked off in the contents.